Asenapine Maleate Crystallization via Phosphate Salt Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying asenapine, particularly in industrial scales, face challenges with low yields and impurity issues due to its oil-like nature and limited crystallization capabilities, making it difficult to obtain high-purity crystalline forms of asenapine maleate.

Innovation Solution

The development of asenapine phosphate, which is synthesized through treatment of crude asenapine with phosphoric acid in organic solvents, resulting in a high-purity, crystalline form with improved filterability and stability, and subsequent conversion to a novel monoclinic polymorphic form of asenapine maleate with enhanced chemico-physical properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If asenapine is purified by conventional crystallization methods, then some purification is achieved, but the yield is low and purity is insufficient due to its oil-like nature

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the chemical parameter by converting asenapine base into asenapine phosphate salt through reaction with phosphoric acid. This parameter change transforms the oil-like asenapine base into a crystalline salt form that can be effectively purified by crystallization, thereby achieving both high purity and high yield simultaneously

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent utilizes phase transition by converting asenapine from its oil phase (base form) to solid crystal phase (phosphate salt form). This phase transition enables the application of crystallization techniques for purification, resolving the contradiction between achieving high purity and maintaining high yield

Inventive Principle:
Principle #36Phase transitions

2Ease of manufacture

If asenapine base is used directly, then no salt conversion is needed, but it cannot be purified by crystallization and remains impure

Engineering Contradiction:
Improveprocess simplicityVSAvoidpurity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent applies parameter change by converting asenapine base to asenapine phosphate salt, enabling crystallization-based purification. The process simplicity is maintained through a straightforward acid-base reaction followed by crystallization, achieving both ease of manufacture and high purity

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If conventional purification methods are used, then some impurities are removed, but filterability is poor and stability is insufficient

Engineering Contradiction:
ImprovepurityVSAvoidfilterability
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent utilizes phase transition to convert asenapine from oil phase to crystalline solid phase through salt formation. The crystalline structure of asenapine phosphate provides excellent filterability and enhanced stability, resolving the contradiction between purification effectiveness and operational ease

Inventive Principle:
Principle #36Phase transitions

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the production of asenapine maleate with high yields and purity exceeding 99.5%, along with improved stability and filterability, facilitating its use in pharmaceutical compositions.

Implementation Method 1

asenapine phosphate, which is synthesized through treatment of crude asenapine with phosphoric acid

Methodology Applied
Scientific EffectAcid-base neutralization: Chemical Bonding

Implementation Method 2

the product is characterised by crystallinity, high HPLC purity (exceeding 99.5%), excellent filterability

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 3

its use to prepare asenapine maleate

Methodology Applied
Scientific EffectSalt conversion: Chemical Bonding

Data Source

PatentUS9447109B2Crystalline salts of asenapine
Publication Date: 2016.09.20 OLON SPA
  • US9447109B2 patent drawing
  • US9447109B2 patent drawing
  • US9447109B2 patent drawing

AI summary

Disclosed is asenapine phosphate of formula (I) and its enantiomer (I) which can be used to prepare asenapine maleate. Further disclosed is a monoclinic crystalline form of asenapine maleate.